# tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study

> **NCT04883229** · NA · WITHDRAWN · sponsor: **University of California, San Francisco**

## Conditions studied

- Nonfluent Aphasia, Progressive
- Primary Progressive Nonfluent Aphasia
- Primary Progressive Non Fluent Aphasia
- Progressive Supranuclear Palsy
- Corticobasal Degeneration
- Behavioral Variant of Frontotemporal Dementia

## Interventions

- **DEVICE:** Halo Neuroscience Neurostimulator

## Key facts

- **NCT ID:** NCT04883229
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-07-01
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The tDCS device that was going to be used for this study is no longer being made.
- **Last updated:** 2022-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04883229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04883229, "tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04883229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*